These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 19017951)
1. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. Chaigne-Delalande B; Guidicelli G; Couzi L; Merville P; Mahfouf W; Bouchet S; Molimard M; Pinson B; Moreau JF; Legembre P J Immunol; 2008 Dec; 181(11):7630-8. PubMed ID: 19017951 [TBL] [Abstract][Full Text] [Related]
2. An atypical necrotic signal induced by immunosuppressive and anti-viral agents. Chaigne-Delalande B; Guidicelli G; Couzi L; Legembre P Autophagy; 2009 Apr; 5(3):425-7. PubMed ID: 19221465 [TBL] [Abstract][Full Text] [Related]
3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Allison AC; Eugui EM Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053 [TBL] [Abstract][Full Text] [Related]
4. The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells. Guidicelli G; Chaigne-Delalande B; Dilhuydy MS; Pinson B; Mahfouf W; Pasquet JM; Mahon FX; Pourquier P; Moreau JF; Legembre P PLoS One; 2009; 4(5):e5493. PubMed ID: 19430526 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749 [TBL] [Abstract][Full Text] [Related]
6. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of mycophenolate mofetil. Allison AC Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil and its mechanisms of action. Allison AC; Eugui EM Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Dayton JS; Turka LA; Thompson CB; Mitchell BS Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen. Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080 [TBL] [Abstract][Full Text] [Related]
13. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil. Griesmacher A; Weigel G; Seebacher G; Müller MM Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471 [No Abstract] [Full Text] [Related]